Glixi Quant is a systematic investment firm applying quantitative research and disciplined execution across global markets.
Glixi Quant was founded with a singular purpose: to construct investment strategies where every decision is driven by evidence, not intuition. We believe the best outcomes emerge when rigorous quantitative research is paired with systematic, emotionless execution.
Our team has spent years designing, testing, and refining a multi-strategy ensemble that spans equities, fixed income, commodities, and cross-asset portfolios. We operate with institutional standards of transparency and risk management — regardless of account size.
Every strategy we deploy has been subjected to walk-forward validation across multiple years of unseen market data. We control for multiple-testing bias, overfitting, and regime shifts — the three silent killers of quantitative strategies.
We believe in radical transparency. Our live portfolio runs on Interactive Brokers with every position auditable in real time. We publish what we do — because we're confident in how we do it.
We don't predict where markets will go. We build systems that systematically capture opportunities — and manage risk — across all environments.
Every strategy must demonstrate statistical significance on data it has never seen. We apply Deflated Sharpe Ratio correction across thousands of tested configurations to ensure our results are not artifacts of chance.
No single strategy defines us. We operate multiple independent blocks — each exploiting a different market inefficiency — combined through statistical portfolio construction. When one falters, others compensate.
Our systems execute without human intervention. No second-guessing, no emotional overrides. Weekly rebalancing follows the same rigorous process whether markets are calm or in turmoil.
"In the short run, the market is a voting machine. In the long run, it is a weighing machine."
Our approach combines multiple quantitative strategies into a single portfolio — designed to generate returns across different market conditions with controlled risk.
We work with institutional allocators and individual investors who value systematic process and full transparency.
Direct allocation through your existing brokerage. Customizable risk parameters, full reporting, complete audit trail.
Our strategy is now officially listed as DARWIN PNTK on Darwinex Zero. Investors can track performance and subscribe directly.